Mark Rochman, PhD, Jared Travers, BS, Cora E. Miracle, Mary C

Slides:



Advertisements
Similar presentations
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Advertisements

Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer  Tali Czarnowicki, MD, Dana Malajian, BA, Saakshi Khattri, MD,
Induced sputum proteome in healthy subjects and asthmatic patients
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications  Mayte.
Asthma inflammatory phenotypes show differential microRNA expression in sputum  Tania Maes, PhD, Francisco Avila Cobos, MSc, Florence Schleich, MD, PhD,
Ariel Munitz, PhD, Amanda Waddell, BSc, Luqman Seidu, MD, Eric T
Transcriptome analysis of proton pump inhibitor–responsive esophageal eosinophilia reveals proton pump inhibitor–reversible allergic inflammation  Ting.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Ryan H. Dougherty, MD, Sukhvinder S
Regulation of GM-CSF expression by the transcription factor c-Maf
Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells  Youwen Yang, PhD, Hans Michael Haitchi, MD,
Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue  Jolien Suurmond, MSc, Kim L.L. Habets,
Epithelial proteome profiling suggests the essential role of interferon-inducible proteins in patients with allergic rhinitis  Joseph Ndika, PhD, Liisa.
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome 
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,
MicroRNA activation signature in patients with hemophagocytic lymphohistiocytosis and reversibility with disease-specific therapy  Janos Sumegi, MD, PhD,
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3  Kevin O. Kisich, PhD, Charles.
Deficient glucocorticoid induction of anti-inflammatory genes in nasal polyp fibroblasts of asthmatic patients with and without aspirin intolerance  Laura.
Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease  Alex Poole, MS, Cydney Urbanek, BS, Celeste Eng, BS, Jeoffrey.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
D prostanoid receptor 2 (chemoattractant receptor–homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects.
Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis  Marc E. Rothenberg, MD, PhD, Ting Wen, PhD, Allison Greenberg, BA, Oral.
Signaling through FcRγ-associated receptors on dendritic cells drives IL-33–dependent TH2-type responses  Melissa Y. Tjota, BA, Cara L. Hrusch, PhD, Kelly.
Ariel Munitz, PhD, Amanda Waddell, BSc, Luqman Seidu, MD, Eric T
Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2
IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids  Carine Blanchard, PhD, Melissa K. Mingler,
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease  Kathryn L.
Eosinophilic esophagitis: Epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment  Amir F. Kagalwalla, MD,
Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation  David F. Choy, BS, Daniel K. Hsu, PhD,
Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease  John W. Steinke, PhD, Lixia Liu, MD, Phillip Huyett, MD, Julie Negri,
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Katherine G. MacDonald, BSc, Nicholas A. J
FcɛRI cross-linking and IL-3 protect human basophils from intrinsic apoptotic stress  Lionel Rohner, MSc, Ramona Reinhart, PhD, Björn Hagmann, PhD, Andrea.
An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: Integration of machine learning  Benjamin F. Sallis, BS, Lena Erkert,
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling  Wataru.
Fibronectin is a TH1-specific molecule in human subjects
Yifang Chen, Devendra S. Mistry, George L. Sen 
Elucidating the effects of disease-causing mutations on STAT3 function in autosomal- dominant hyper-IgE syndrome  Simon J. Pelham, MSc, Helen C. Lenthall,
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis  Deepti R. Nagarkar, PhD, Julie A. Poposki,
Downregulation of a disintegrin and metalloproteinase 33 by IFN-γ in human airway smooth muscle cells  Isao Ito, MD, PhD, Johanne D. Laporte, PhD, Pierre.
Streptococcus pyogenes–induced cutaneous lymphocyte antigen–positive T cell– dependent epidermal cell activation triggers TH17 responses in patients with.
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease  Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,
Altered gene expression profiles in nasal respiratory epithelium reflect stable versus acute childhood asthma  Jesus R. Guajardo, MD, MHPE, Kathleen W.
Volume 9, Issue 5, Pages (November 2017)
Fibronectin is a TH1-specific molecule in human subjects
Nasal mucus proteomic changes reflect altered immune responses and epithelial permeability in patients with allergic rhinitis  Peter Valentin Tomazic,
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
J. Pablo Abonia, MD, Ting Wen, PhD, Emily M
Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma  Kandace Bonner, BSc, Harsha H.
TGF-β1–induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis  Lisa Y. Beppu, BS,
Volume 17, Issue 3, Pages (October 2016)
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling  Wataru.
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease  Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,
Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells  Hong Ji, PhD, Xue Zhang,
Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps  Javier Milara, PhD, PharmD, Teresa Peiró,
Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4  Michael B. Soyka, MD, Paulina Wawrzyniak,
Anti–IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis  Iris M. Otani, MD, Arjun A. Anilkumar,
Vaccinia virus–specific molecular signature in atopic dermatitis skin
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Eosinophilic esophagitis versus proton pump inhibitor–responsive esophageal eosinophilia: Transcriptome analysis  Tetsuo Shoda, MD, PhD, Akio Matsuda,
A flow cytometry–based diagnosis of eosinophilic esophagitis
Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis  Jennifer K. Mulligan, PhD, Whitney Nagel,
Bleomycin hydrolase downregulation in lesional skin of adult atopic dermatitis patients is independent of FLG gene mutations  Laurence Pellerin, PhD,
TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic.
Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes  Matthew A. Tyler, MD, Chris B.
IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitis  Janine Bilsborough, PhD, Donald.
Transforming growth factor β1 increases fibronectin deposition through integrin receptor α5β1 on human airway smooth muscle  Lyn M. Moir, PhD, Janette.
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Presentation transcript:

Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis  Mark Rochman, PhD, Jared Travers, BS, Cora E. Miracle, Mary C. Bedard, BS, Ting Wen, PhD, Nurit P. Azouz, PhD, Julie M. Caldwell, PhD, Kiran KC, BS, Joseph D. Sherrill, PhD, Benjamin P. Davis, MD, PhD, Jeffrey K. Rymer, BS, Kenneth M. Kaufman, PhD, Bruce J. Aronow, PhD, Marc E. Rothenberg, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 140, Issue 3, Pages 738-749.e3 (September 2017) DOI: 10.1016/j.jaci.2016.11.042 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Altered transcription of esophagus-specific genes in patients with EoE. A, Graph shows percentage of organ-specific genes altered in the EoE transcriptome, as assessed by means of RNA sequencing.3 B, Venn diagram shows overlap of genes specifically expressed in the esophagus according to the Human Protein Atlas (Esophagus) with genes differentially expressed in the esophageal tissue of patients with active EoE compared with control esophageal tissue (EoE). For each group of genes (see the text and the Methods section for definitions), the number of upregulated (Up) and downregulated (Down) genes is shown (not to scale). A set of 117 overlapping genes is designated as Eso-EoE genes. C, Normalized expression levels for each gene (fragments per kilobase per million reads [FPKM]) in esophageal biopsy tissue from patients with active EoE (EoE, blue rectangles, n = 10) and control subjects (Ctrl, green rectangles, n = 6) for the 12 genes most highly expressed in the homeostatic esophagus are presented as a box-and-whiskers plot. Genes upregulated in samples from patients with active EoE are in orange. The P value for each gene is shown on the right. Statistical significance was determined by using the Holm-Sidak method. D, Venn diagram shows the overlap of genes specifically expressed in the stomach according to the Human Protein Atlas with genes differentially expressed in biopsy specimens of patients with EG.14 Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Functional enrichment analysis of esophagus-specific Eso-EoE genes altered in patients with EoE. Shown are the 10 most significant terms identified for Eso-EoE genes by functional enrichment analysis in the following categories: Molecular Function (A), Biological Processes (B), Human Phenotype (C), and Protein Domain (D). Genes for the selected terms (gray bars) are listed with the corresponding fold change in expression for active EoE (EoE) compared with control (Ctrl) samples. Upregulated genes are in orange. The x-axes represent the negative log10 P value. Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Effect of differentiation on expression of esophagus-specific Eso-EoE genes. A, Schematic diagram for generating ALI cultures from EPC2 esophageal epithelial cells is shown. Cells are initially grown in submerged culture at low and then high calcium concentrations to promote initial differentiation; terminal differentiation is achieved by growing cells in ALI. Note that the presence of IL-13 during the differentiation process weakens esophageal epithelial integrity, as represented by increased spaces between cell layers. B, Venn diagram shows overlap between Eso-EoE genes and transcriptional changes during initial differentiation. A heat map represents log2 fold change in gene expression when comparing biopsy specimens from patients with EoE with normal biopsy specimens and comparing day 8 with day 3 (Initial Diff). The analysis is focused on the 90 common Eso-EoE genes. Clustering was performed by using Euclidean distance and average linkage parameters; yellow and blue colors correspond to increased or decreased expression, respectively; and black indicates a nonsignificant change compared with control values. Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Effect of IL-13 treatment on expression of esophagus-specific Eso-EoE genes at the ALI. A, Venn diagram shows overlap of Eso-EoE genes with transcriptional signature of terminally differentiated ALI in the absence or presence of IL-13. D0 represents the first day and D6 represents the last day of terminal differentiation at ALI (see Fig 3 for details). Group 1 shows 32 genes altered in biopsy specimens and in the ALI in the presence and absence of IL-13. Group 2 shows 8 genes with altered expression in biopsy specimens and in the presence of IL-13 during ALI (D6 vs D6 + IL-13). Group 3 shows 28 genes with altered expression in biopsy specimens and by ALI differentiation but was not affected by IL-13 (D6 vs D0). B, Heat map shows a log2 fold change in expression of genes from the IL-1 and SERPINB gene families in biopsy specimens and ALI culture from patients with EoE at the indicated conditions. Orange color represents increased expression of SERPIN genes in biopsy specimens from patients with EoE. For Fig 4, A and B, the heat maps show the log2 fold change in expression of genes from indicated groups. For all heat maps, the EoE biopsy specimen represents the expression level of the indicated genes in the EoE transcriptome compared with that in unaffected subjects. Clustering was performed by using Euclidean distance and average linkage parameters. Yellow and blue colors correspond to increased or decreased expression, respectively, and black color indicates a nonsignificant change compared with control subjects. C, Expression level of indicated Eso-EoE genes after the EoE diagnostic panel analysis23 was assessed by using RT-PCR in control subjects (Ctrl), patients with active EoE (EoE), and patients with gastroesophageal reflux disease (GERD). Each dot represents an individual biopsy specimen, and expression was normalized to GAPDH. Error bars represent the SEM of the mean relative expression. *P < .05, **P < .01, and ***P < .001, 1-way ANOVA. ns, Not significant. Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Protein expression, protease activity, and expression of differentiation markers in esophageal biopsy specimens of patients with EoE. A, Representative Western blot for the indicated proteins in control (Ctrl) and active EoE (EoE) samples (n = 3 biopsy specimens). Red and green arrows point to the bands corresponding to analyzed proteins; molecular weight markers are shown on the right. B, Graphs show relative expression of the indicated proteins normalized to the loading control (HSP90) by using Western blotting (n = 5-10 samples for each group). Error bars represent the SEM of the mean relative expression. *P < .05 and **P < .01, Mann-Whitney test. C-F, Immunofluorescence of distal esophageal biopsy specimens from control subjects (Ctrl, top row) or patients with active EoE (EoE Inflamed, middle row) or proximal esophageal biopsy specimens from regions that do not have active inflammation from patients with active EoE (EoE Non-inflamed, bottom row). Staining with the nuclear dye DAPI or with an antibody directed against the indicated differentiation marker (KRT5, KRT14, KRT4, or CRNN) are indicated by blue or green, respectively. White broken line indicates basal membrane. Scale bar = 100 μm. Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Model of esophagus-specific allergic inflammation. Under healthy conditions, the esophagus expresses tissue-specific markers of terminal epithelial differentiation (represented by KRT4 and CRNN). Profound loss of esophageal differentiation, either acquired or genetically inherited (represented by loss of KRT5 and KRT14), predisposes and/or propagates EoE. Loss of differentiation is triggered by imbalanced proteolytic activity in the esophagus, as indicated by the ratio between proteases and protease inhibitors (note that protease and protease inhibitors can be either upregulated or downregulated in patients with EoE). Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Effect of IL-1α replenishment on ALI. A, Relative transepithelial electrical resistance (TEER) in EPC2 ALI cultures treated with IL-13 and IL-1α either alone or in combination. IL-13 treatment was started when ALI was induced at day 8, and IL-1α was added for the last 2 days of culture. TEER measurements were normalized to average TEER in the untreated (Ctrl) cultures at day 4. B, Expression level of CCL26 and SERPINB4 was assessed by using RT-PCR. Expression was normalized to GAPDH. Combined data for 2 independent experiments are shown. Journal of Allergy and Clinical Immunology 2017 140, 738-749.e3DOI: (10.1016/j.jaci.2016.11.042) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions